Angiogenesis and Lymphangiogenesis in Medulloblastoma Development
Biology, ISSN: 2079-7737, Vol: 12, Issue: 7
2023
- 3Citations
- 10Captures
- 2Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations3
- Citation Indexes3
- CrossRef2
- Captures10
- Readers10
- 10
- Mentions2
- Blog Mentions1
- 1
- News Mentions1
- 1
Most Recent Blog
Biology, Vol. 12, Pages 1028: Angiogenesis and Lymphangiogenesis in Medulloblastoma Development
Biology, Vol. 12, Pages 1028: Angiogenesis and Lymphangiogenesis in Medulloblastoma Development Biology doi: 10.3390/biology12071028 Authors: Manon Penco-Campillo Gilles Pages Sonia Martial Medulloblastoma (MB) is the
Most Recent News
New Findings from Institute for Research on Cancer and Aging Describe Advances in Medulloblastoma (Angiogenesis and Lymphangiogenesis in Medulloblastoma Development)
2023 AUG 03 (NewsRx) -- By a News Reporter-Staff News Editor at Angiogenesis Daily -- Current study results on medulloblastoma have been published. According to
Review Description
Medulloblastoma (MB) is the most prevalent brain tumor in children. Although the current cure rate stands at approximately 70%, the existing treatments that involve a combination of radio- and chemotherapy are highly detrimental to the patients’ quality of life. These aggressive therapies often result in a significant reduction in the overall well-being of the patients. Moreover, the most aggressive forms of MB frequently relapse, leading to a fatal outcome in a majority of cases. However, MB is highly vascularized, and both angiogenesis and lymphangiogenesis are believed to play crucial roles in tumor development and spread. In this context, our objective is to provide a comprehensive overview of the current research progress in elucidating the functions of these two pathways.
Bibliographic Details
MDPI AG
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know